地舒单抗及RANKL受体抑制剂疗效更佳
Overall, both Denosumab and other RANKL receptor inhibitors represented by it have better effects, whether in comparing individual drugs or classifying drugs based on mechanisms.
原文地址: https://www.cveoy.top/t/topic/o6YB 著作权归作者所有。请勿转载和采集!